“Find out which medical conditions qualify for cannabis treatment at FloweretMD. Get detailed information on eligibility, application processes, and how we can assist in your healthcare journey.”

To qualify for a medical cannabis prescription in Texas, you must be a permanent resident of the state and have one of the following conditions:
- ALS,
- Alzheimer’s disease,
- Autism,
- Cerebral Palsy,
- Chronic Traumatic Brain Encephalopathy,
- Epilepsy and other Seizure disorders,
- Huntington’s disease,
- Multiple Sclerosis,
- Muscular Dystrophy,
- Parkinson’s disease,
- Peripheral Neuropathies,
- PTSD
- Muscle Spasms,
- Spasticity,
- Spinal Muscular Atrophy,
- All Cancers
- or Incurable Neurodegenerative Diseases.
The Texas Administrative Code defines an incurable neurodegenerative disease as a condition, injury, or illness: (1) that occurs when nerve cells in the brain or peripheral nervous system lose function over time; and (2) for which there is no known cure.
Full list of Incurable Neurodegenerative Diseases
- 3-hydroxy-3-methylglutaryl-CoA lyase deficiency
- 5-aminoimidazole-4-carboxamide ribonucleotide transformylase deficiency;
- Adenylosuccinate synthase Deficiency
- Alexander disease
- Alpers-Huttenlocher syndrome
- Alpha-fucosidosis
- Alzheimer’s Disease
- Amyloidoses
- Amyotrophic lateral Sclerosis
- Argyrophilic Grain Disease
- Aromatic L-amino acid decarboxylase deficiency
- Asparylglucosaminuria
- Ataxia neuropathy spectrum
- Bidirectional enzyme deficiency
- Canavan disease
- Central Core Muscular Dystrophy
- Cerebral Autosomal Dominant Arteriopathy with Sub-cortical Infarcts and Leukoencephalopathy
- Charcot Marie Tooth and related hereditary neuropathies
- Childhood Myocerebrohepatopathy spectrum
- Chronic Traumatic Encephalopathy
- Congenital Disorders of Glycosylation
- Corticobasal Degeneration
- Creatine Transporter Defect, also known as SLC 6A8
- Creutzfeldt-Jakob Disease
- Dementia with Lewy Bodies
- Deoxyguanisine kinase deficiency
- Dihydropirimidinase DeficiencyDihydropyrimidine dehydrogenase Deficiency
- Dihydropteridine reductase defect
- Duchenne Muscular Dystrophy
- Facioscapulohumeral Muscular Dystrophy
- Familial or Sporadic Fatal Insomnia
- Familial Spastic Paraplegia
- Farber Disease
- Freidreich’s Ataxia
- Frontotemporal dementia and parkinsonism linked to chromosome 17 caused by mutations in MAPT gene
- Frontotemporal Lobar Degeneration
- Galactosemia
- Galactosialidosis
- Gaucher Type 2 and Type 3
- Gerstmann-Straussler-Scheinker Disease
- Globular Glial Tauopathy
- Glutaric acidemia type 1
- Glycine encephalopathy, also known as non-ketotic hyperglycinemia
- Glycogen Storage-Lysosomal: Pompe Disease
- GM1 gangliosidosis
- GM2 gangliosidosis, also known as Tay-Sachs and Sandhoff Disease
- Guanidinoacetate methytransferase deficiency
- Guanosine triphosphate cyclohydrolase deficiency
- Homocysteine re-methylation defects
- Hunter Syndrome
- Hurler Syndrome
- Hypoxanthine-guanine phosophoribosyltransferase Deficiency, also known as Lesch-Nyhan disease
- Kearn Sayers Syndrome
- Krabbe
- Kuru
- L-2-hydroxyglutaric aciduria
- L-Arginine/glycine amidinotransferase deficiency
- Leigh syndrome
- Lesch-Nyhan
- leukodystrophy
- Lewy Body Disorders
- Long-chain L-3 hydroxyacyl-CoA dehydrogenase deficiency
- Lysosomal Storage Diseases
- Mannosidosis
- Manosidosis alpha and beta
- Maple Syrup Urine Disease
- Metachromatic leukodystrophy
- Methylenetetrahydrofolate reductase deficiency severe variant
- Mitochondrial Depletion syndromes types 1 through 14
- Mitochondrial Encephalopathy Lactic Acidosis Stroke
- Mitochondrial Encephalopathy Ragged Red Fiber
- Mitochondrial neurogastrointestinal encephalopathy
- Monoamine oxidase deficiency
- Mucolipidoses
- Mucolipidoses Type II, also known as Inclusion Cell disease
- Mucolipidoses Type III, also known as pseudo-Hurler polydystrophy
- Mucopolysaccaridosis
- Mucopolysaccharidosis Type I, also known as Hurler Syndrome or Scheie Syndrome
- Mucopolysaccharidosis Type II, also known as Hunter Syndrome
- Mucopolysaccharidosis Type III, also known as Sanfilippo A and B
- Mucopolysaccharidosis Type IV, also known as Maroteaux-Lamy
- Mucopolysaccharidosis Type VII, also known as Sly
- Multiple Sulfatase deficiency Myoclonic epilepsy myopathy sensory ataxia
- Multiple System Atrophy
- Neimann Pick Type A and B
- Neimann Pick Type C
- Neonatal Adrenoleukodystrophy
- Neurodegeneration with brain iron accumulation
- Neurofibrillary Tangle dementia, also known as Primary Age-related Tauopathy
- Neuronal ceroid lipofuscinosis types 1-10 including Batten Disease
- Neuropathy, Ataxia, and Retinitis Pigmentosa
- Oligosaccharidoses
- Pantothenate Kinase Associated Neurodegeneration
- Parkinson’s Disease
- Pelizaeus-Merzbacher disease
- Peripheral neuropathy types 1 through 4
- Peroxisomal biosynthesis defects
- Pick Disease
- Polyol disorders
- Pompe Disease
- Primary Age-related Tauopathy
- Primary Lateral Sclerosis
- Prion Diseases
- Progressive Choreas: Huntington’s Disease
- Progressive dystonias DYT genes 1 through 20
- Progressive Muscular Atrophy
- Progressive Supranuclear Palsy
- Pterin-4-carbinolamine dehydratase defect
- Pyruvate Carboxylase Deficiency
- Pyruvate Dehydrogenase Deficiency
- Pyruvoyl-tetahydropterin synthase defect
- Refsum Disease
- Respiratory chain disorders complex 1 through 4 defects: Co Q biosynthesis defects
- RRM2B-related mitochondrial disease
- Salidosis
- Sandhoff Disease
- Sanfilippo A and B
- Scheie Syndrome
- Schindler
- Segawa Diease, also known as Dopamine Responsive Dystonia
- Sepiapterin reductase defect
- Sialidosis
- SLC 6A8
- Sly
- Spinal Muscular Atrophy
- Spinal-bulbar muscular atrophy
- Spinocerebellar ataxia
- Subacute necrotizing encephalopathy, also known as Leigh syndrome
- SUCLG1-related mitochondrial DNA depletion syndrome, encephalomyopathic form with methylmalonic aciduria
- Tay-Sachs
- Thymidine Kinase
- Transactive response DNA-binding protein-43 (TDP-43) Proteinopathies
- Trifunctional protein deficiency
- Vascular dementia
- Wilson Disease
- X-linked adrenoleukodystrophy
- Zellweger syndrome
A treating physician of a patient suffering from an incurable neurodegenerative disease not listed in subsection (b) of this section may submit a request to the department to have a disease added.
Get a Little Closer
Subscribe
Sign up to get the latest information on sales, new releases, and more…